Gut neuroendocrine tumors.
Hammond
P J
PJ
Royal Postgraduate Medical School, London, England.
Bloom
S R
SR
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D003981:Diazoxide / Q000627:therapeutic use*; D005047:Etoposide / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D015282:Octreotide / Q000627:therapeutic use*; D009853:Omeprazole / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013311:Streptozocin / Q000008:administration & dosage
D016898:Interferon-alpha; D013311:Streptozocin; D005047:Etoposide; D003606:Dacarbazine; D009853:Omeprazole; D003981:Diazoxide; D002945:Cisplatin; D015282:Octreotide; D005472:Fluorouracil